Chairs: Olivia Pagani (Switzerland), Kathleen Pritchard (Canada)
De-escalating and escalating treatment in patients with HER2 positive breast cancer?
Webcast from Heikki Joensuu, Finland not available
De-escalating and escalating treatment in patients with triple negative breast cancer: Maintenance and post-neoadjuvant setting
Lisa Carey, USA
De-escalating and escalating treatment beyond endocrine therapy in patients with luminal breast cancer
Angelo Di Leo, Italy
Role of bisphosphonates and denosumab in the adjuvant setting
Michael Gnant, Austria
Discussion